Antibiotic Residue Testing

Comprehensive Antibiotic Residue Testing Services – Advanced LC‑MS/MS, HRMS, and Multi‑Residue Screening for Regulatory Compliance and Food Safety

The accurate and reliable detection of antibiotic residues in food, feed, water, and biological samples is a critical requirement for ensuring public health, maintaining consumer confidence, and meeting stringent regulatory standards. Antibiotics are widely used in veterinary medicine and agriculture, and their residues can persist in animal products (meat, milk, eggs, honey), aquaculture products, and the environment, posing risks such as antimicrobial resistance, allergic reactions, and disruption of the human microbiome. Regulatory bodies worldwide – including the US FDA, EU Commission, Codex Alimentarius, and national food safety authorities – have established maximum residue limits (MRLs) for hundreds of antibiotic compounds, demanding rigorous monitoring and enforcement. However, a robust antibiotic residue testing strategy is not a simple “screening” exercise; it requires a sophisticated, multi‑residue, multi‑matrix analytical platform that integrates advanced sample preparation, high‑performance liquid chromatography‑tandem mass spectrometry (LC‑MS/MS), high‑resolution mass spectrometry (HRMS), and, where appropriate, screening immunoassays and microbiological inhibition tests. A poorly designed or executed method can lead to false‑negatives, false‑positives, incorrect quantification, or failure to detect banned or emerging substances, with serious consequences for product safety and regulatory compliance. Our ISO/IEC 17025‑accredited and GMP‑compliant laboratory offers a fully integrated antibiotic residue testing platform, covering the entire spectrum from rapid screening to confirmatory quantification and unknown identification. We deliver quantitative, traceable results, including the identification and quantification of over 200 antibiotic compounds (covering all major classes: β‑lactams, tetracyclines, aminoglycosides, macrolides, fluoroquinolones, sulfonamides, amphenicols, and many others) at sub‑ppb levels, with full compliance to the latest MRLs and regulatory guidance. Our expert analytical chemists provide comprehensive interpretation and actionable recommendations, enabling you to ensure product safety, meet export requirements, and protect your brand reputation.

1. The Scientific and Regulatory Imperative for Antibiotic Residue Testing

Antibiotic residue testing serves multiple critical purposes: (a) to verify that animal‑derived food products (meat, milk, eggs, honey, fish) meet the legally established maximum residue limits (MRLs); (b) to monitor the withdrawal periods after veterinary treatment; (c) to detect the illegal use of banned substances (e.g., chloramphenicol, nitrofurans, nitroimidazoles); (d) to assess the environmental impact of antibiotic use through water and soil monitoring; (e) to support antimicrobial resistance (AMR) surveillance by linking residue levels to resistance development; and (f) to fulfil the import/export testing requirements of different countries. The choice of analytical approach – whether screening methods (ELISA, microbial inhibition tests, biosensors) or confirmatory methods (LC‑MS/MS, HRMS, GC‑MS) – must be tailored to the compound(s) of interest, the matrix (e.g., muscle, liver, milk, honey, eggs, water, feed), the required detection limit, and the regulatory context. A method that is adequate for a simple screening may not provide the specificity and sensitivity required for regulatory enforcement, and a method that works for a single compound may fail to detect the wide range of residues that can be present. Our service begins with a comprehensive consultation to define the optimal testing strategy for your product, your target compounds, and your regulatory jurisdiction, ensuring both scientific rigour and operational efficiency.

2. Our Comprehensive Antibiotic Residue Testing Platform – Multi‑Technology, Multi‑Matrix

We maintain a complete suite of validated antibiotic residue testing methods, all performed in a dedicated analytical facility with stringent quality controls, and using certified reference materials (CRMs) and stable isotope‑labelled internal standards for accurate quantification. Our portfolio includes:

2.1 High‑Performance Liquid Chromatography‑Tandem Mass Spectrometry (LC‑MS/MS) – The Gold Standard for Quantification
We perform LC‑MS/MS using state‑of‑the‑art triple quadrupole mass spectrometers (e.g., Sciex 6500+, Waters Xevo TQ‑XS) operating in multiple reaction monitoring (MRM) mode. We have developed and validated multi‑residue methods that cover over 200 antibiotic compounds from all major classes, including: β‑lactams (penicillins, cephalosporins), tetracyclines, aminoglycosides, macrolides, fluoroquinolones, sulfonamides, amphenicols (chloramphenicol, florfenicol), nitrofurans (as metabolites), nitroimidazoles, lincosamides, pleuromutilins, and many others. The methods are validated for a wide range of matrices (muscle, liver, kidney, milk, honey, eggs, aquaculture products, water, feed) with limits of quantification (LOQs) well below the regulatory MRLs, typically in the low ppb (μg/kg) to sub‑ppb range. We include stable isotope‑labelled internal standards for each compound class to correct for matrix effects and extraction losses, ensuring high accuracy and precision.

2.2 High‑Resolution Mass Spectrometry (HRMS) – Untargeted Screening and Unknown Identification
For the detection of unexpected, banned, or emerging antibiotic residues, we use HRMS (Q‑TOF or Orbitrap) in full‑scan and data‑dependent acquisition (DDA) modes. This allows us to screen for thousands of compounds simultaneously, including known antibiotics and their metabolites, and to identify unknown peaks by accurate mass, isotopic pattern, and MS/MS fragmentation. We use comprehensive databases (e.g., mzCloud, ChemSpider, and in‑house libraries) to provide tentative identification and, where possible, to confirm the identity and quantify using reference standards. This service is essential for investigating contamination events, for monitoring the presence of “designer” or unapproved antibiotics, and for ensuring that your product is free from any undeclared residues.

2.3 Rapid Screening – ELISA, Microbial Inhibition Tests, and Lateral Flow Devices
For high‑throughput screening and for on‑site testing, we offer ELISA (enzyme‑linked immunosorbent assay), microbial inhibition tests (e.g., the Four‑Plate Test, or the Premi®Test), and lateral flow immunoassays (strip tests) for specific antibiotics or groups. These methods provide a rapid (2‑4 hours) qualitative or semi‑quantitative result and are ideal for initial screening, for monitoring compliance at the production line, and for reducing the number of confirmatory analyses. All positive or suspicious results are confirmed by LC‑MS/MS or HRMS.

2.4 Multi‑Residue Sample Preparation – QuEChERS, SPE, and Automated Extraction
We employ validated sample preparation protocols that are optimised for each matrix and compound class. Our methods include: (a) QuEChERS (Quick, Easy, Cheap, Effective, Rugged, and Safe) for muscle, liver, and other high‑fat matrices; (b) solid‑phase extraction (SPE) for milk, honey, and water; (c) acidic hydrolysis and derivatisation for aminoglycosides and nitrofurans; and (d) automated liquid‑handling systems for high‑throughput extraction. We ensure that each extraction method is fully validated for recovery (typically 70‑120%), reproducibility (RSD < 15%), and stability, and we incorporate the use of internal standards to correct for any variability.

2.5 Confirmatory Analysis and Quantification – Strict Quality Control
All positive findings from screening are subjected to confirmatory analysis using LC‑MS/MS or HRMS, following the EU Decision 2002/657/EC criteria (identification points, retention time, ion ratios, and MS/MS transitions). We perform quantification against matrix‑matched calibration curves to compensate for matrix effects, and we include quality control (QC) samples at the MRL and at the LOQ levels in every batch to monitor performance. We report the concentrations in μg/kg (ppb) or μg/L, with the expanded measurement uncertainty (k=2), ensuring that the results are legally defensible.

2.6 Stability and Degradation Studies – Assessing Residue Persistence
We offer stability studies to assess the degradation of antibiotic residues under different storage conditions (time, temperature, light, pH) and in different matrices. This is essential for determining the shelf‑life of samples, for interpreting results from stored samples, and for understanding the behaviour of residues during processing. We provide a detailed report of the degradation kinetics and the half‑life of the compound in the matrix.

2.7 Metabolite and Marker Residue Detection – Covering Total Residue
For certain antibiotics (e.g., nitrofurans, chloramphenicol, and some β‑lactams), the regulatory MRLs are based on the sum of the parent compound and its major metabolites (or on specific marker residues). We have validated methods for the detection and quantification of nitrofuran metabolites (AOZ, AMOZ, AHD, SEM), chloramphenicol (as free and bound), and for the total residue (parent plus metabolites) of compounds such as tetracyclines and fluoroquinolones, ensuring that our results are fully compliant with the regulatory requirements.

3. Advanced Capabilities – Emerging Contaminants, Biomarker Studies, and Method Development

For clients requiring a deeper level of characterisation or a high‑level validation of their testing programme, we offer a suite of customised, research‑grade services that go beyond routine residue analysis:

3.1 Untargeted Metabolomics – Profiling of All Chemical Residues
We use HRMS‑based metabolomics to perform a comprehensive, non‑targeted analysis of all chemical contaminants in a sample, including antibiotics, their metabolites, and other exogenous compounds. This is invaluable for identifying the presence of unknown or unexpected contaminants, for comparing batches, and for supporting forensic investigations. We provide a full report of all detected features, with tentative identification and, if possible, semi‑quantitative estimation.

3.2 Biotransformation and Metabolism Studies – Understanding Residue Fate
We can conduct in vitro metabolism studies (using liver microsomes or hepatocytes) to identify the major metabolites of a new antibiotic candidate, or to study the degradation pathways in food‑producing animals. This is essential for the development of new antibiotics, for establishing appropriate withdrawal periods, and for designing effective residue monitoring programmes.

3.3 Method Development and Full Validation – Customised to Your Needs
We develop and validate custom methods for new antibiotics, for unusual matrices, or for compounds that are not covered by standard procedures. The validation follows the guidelines of ICH Q2(R1), FDA, and EU 2002/657/EC, and includes the determination of: (a) selectivity; (b) linearity; (c) accuracy (recovery); (d) precision (repeatability and reproducibility); (e) limit of detection (LOD) and limit of quantification (LOQ); (f) matrix effects; and (g) stability. We provide a comprehensive validation report that is directly usable for regulatory submissions.

3.4 Environmental Residue Monitoring – Water, Soil, and Sediment Analysis
We extend our antibiotic residue testing to environmental matrices (surface water, groundwater, soil, sediment, and wastewater). We use specialised extraction techniques (e.g., solid‑phase extraction, accelerated solvent extraction) and sensitive MS detection to quantify residues at the ng/L or μg/kg levels, supporting environmental risk assessments and AMR surveillance.

3.5 Data Review and Regulatory Submission Support
Our team of experienced analytical chemists and regulatory specialists can assist you in the interpretation of the results, in the preparation of the required documentation for regulatory submissions (e.g., MRL applications, veterinary drug registration), and in responding to queries from authorities. We provide a full data package, including the raw chromatograms, the calibration curves, the QC data, and the uncertainty budgets.

4. Data Integrity, Standardisation, and Comprehensive Reporting

All analyses are conducted under a strict quality management system that includes the use of certified reference materials, routine system suitability tests, and participation in proficiency testing schemes (e.g., FAPAS, ERA, and EU‑RL PTs). Our reports provide:

• Full method description – detailing the sample preparation, the chromatographic conditions, the MS parameters, and the data processing (integration, calibration).
• Detailed results – including the identity (retention time, ion ratios, MS/MS spectra), the concentration (μg/kg or μg/L), the measurement uncertainty (k=2), and the MRL compliance status (pass/fail).
• Quality control data – including the recovery rates, the RSD of replicates, and the results of the QC samples, confirming the validity of the run.
• Graphical outputs – including chromatograms, calibration curves, and, where applicable, mass spectra of the identified compounds.
• Interpretative comments – by our senior analytical chemists, providing a clear statement on the compliance with the relevant regulations, the potential implications, and the recommended actions.

Our reports are structured to meet the requirements of regulatory audits, customer inspections, and internal quality assurance.

Turnaround times: 3‑5 working days for routine LC‑MS/MS screening, 2‑3 working days for ELISA screening, and 1‑2 weeks for full method development or untargeted HRMS profiling. Express services are available for urgent cases.

5. Why Choose Our Laboratory for Antibiotic Residue Testing

We are one of the few laboratories that hold ISO/IEC 17025 accreditation and GMP compliance for antibiotic residue testing, covering all major compound classes and matrices. Our integrated infrastructure combines state‑of‑the‑art LC‑MS/MS and HRMS platforms, automated sample preparation systems, and a dedicated bioinformatics unit – enabling cross‑verification of results and a comprehensive coverage of the residue profile. Our team comprises PhD‑level analytical chemists, food safety experts, and regulatory specialists with extensive experience in method development, validation, and regulatory submissions, and we have a proven track record of supporting food producers, veterinarians, and regulatory agencies.

We offer unparalleled flexibility: we accept all types of samples (animal tissues, milk, honey, eggs, aquaculture products, water, feed, and environmental samples) and we provide customised testing panels that cover your specific compound list and MRLs. Our secure online portal enables real‑time tracking, access to raw data, and downloadable certificates of analysis.

Our modular pricing ensures cost‑effectiveness: you select the level of analysis – from a simple screening to a full multi‑residue confirmatory package – with discounts for routine monitoring programmes and bulk submissions. We also provide training, method transfer, and technical consultancy to help you build or strengthen your internal residue testing capabilities.

With a proven history of serving over 100 clients in the food, feed, and pharmaceutical sectors, we have enabled our partners to achieve regulatory compliance, protect consumer health, and maintain market access. We invite you to leverage our expertise for your antibiotic residue testing needs.

Contact our technical experts today to discuss your products, your target compounds, and your specific regulatory requirements. We will design a tailored testing plan and provide a detailed proposal within one business day.